Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: A systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data

Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: A systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data

Background: Achieving adequate antimalarial drug exposure is essential for curing malaria. Day 7 blood or plasma lumefantrine concentrations provide a simple measure of drug exposure that correlates well with artemether-lumefantrine efficacy. However, the 'therapeutic' day 7 lumefantrine c...

Detaylı Bibliyografya
Asıl Yazarlar:	Ashley, E, Aweeka, F, Barnes, K, Bassat, Q, Borrmann, S, Dahal, P, Davis, T, Deloron, P, Denis, M, Djimde, A, Faucher, J, Genton, B, Guérin, P, Hamed, K, Hodel, E, Huang, L, Jullien, V, Karunajeewa, H, Kiechel, JR, Kofoed, P, Lefèvre, G, Lindegardh, N, Marsh, K, Mårtensson, A, Mayxay, M, McGready, R, Moreira, C, Newton, P, Ngasala, B, Nosten, F, Nsanzabana, C, Parikh, S, Price, R, Ringwald, P, Rombo, L, Schramm, B, Sibley, C, Stepniewska, K, Ursing, J, Vugt, M, White, N, Workman, L
Materyal Türü:	Journal article
Baskı/Yayın Bilgisi:	BioMed Central 2015

Benzer Materyaller

Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis
Yazar:: Kloprogge, F, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Similar efficacy and tolerability of double-dose chloroquine and artemether-lumefantrine for treatment of Plasmodium falciparum infection in Guinea-Bissau: a randomized trial.
Yazar:: Ursing, J, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data
Yazar:: Anstey, N, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda.
Yazar:: Mwesigwa, J, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Population pharmacokinetics and pharmacodynamics of lumefantrine in young Ugandan children treated with artemether-lumefantrine for uncomplicated malaria
Yazar:: Tchaparian, E, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis.
Yazar:: Frank Kloprogge, ve diğerleri
Baskı/Yayın Bilgisi: (2018-06-01)

Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.
Yazar:: Venkatesan, M, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine in combination treatment of uncomplicated falciparum malaria in pediatric patients
Yazar:: Hietala, S, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Artemether-lumefantrine treatment failure despite adequate lumefantrine day 7 concentration in a traveller with Plasmodium falciparum malaria after returning from Tanzania.
Yazar:: Färnert, A, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine during combination treatment in children with uncomplicated falciparum malaria in Tanzania.
Yazar:: Hietala, S, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia.
Yazar:: Denis, M, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Severe acute malnutrition results in lower lumefantrine exposure in children treated with artemether‐lumefantrine for uncomplicated malaria
Yazar:: Chotsiri, P, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

DRUG-DRUG INTERACTIONS BETWEEN ARTEMETHER/LUMEFANTRINE AND LOPINAVIR/RITONAVIR IN HIV NEGATIVE HEALTHY VOLUNTEERS
Yazar:: German, P, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1.
Yazar:: Mwai, L, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Lopinavir/ritonavir affects pharmacokinetic exposure of artemether/lumefantrine in HIV-uninfected healthy volunteers.
Yazar:: German, P, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

High throughput assay for the determination of lumefantrine in plasma.
Yazar:: Annerberg, A, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

EFFICACY OF ARTESUNATE-AMODIAQUINE (ASAQ) AND ARTEMETHER-LUMEFANTRINE (AL) FIXED DOSE COMBINATIONS (FDCS) FOR THE TREATMENT OF UNCOMPLICATED PLASMODIUM FALCIPARUM (PF) MALARIA IN NIMBA COUNTY, LIBERIA
Yazar:: Schramm, B, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria.
Yazar:: van Vugt, M, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
Yazar:: Mcgready, R, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective study.
Yazar:: Ngasala, B, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
Yazar:: McGready, R, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Drug interactions between dolutegravir and artemether-lumefantrine or artesunate-amodiaquine
Yazar:: Walimbwa, S, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia
Yazar:: Otienoburu, SD, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

How much fat is necessary to optimize lumefantrine oral bioavailability?
Yazar:: Ashley, E, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Pharmacokinetic properties of artemether, dihydroartemisinin, lumefantrine, and quinine in pregnant women with uncomplicated plasmodium falciparum malaria in Uganda.
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine.
Yazar:: van Vugt, M, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine
Yazar:: White, N, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria.
Yazar:: Vugt, M, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Artemether-lumefantrine coadministration with antiretrovirals; population pharmacokinetics and dosing implications.
Yazar:: Hoglund, R, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Lumefantrine attenuates Plasmodium falciparum artemisinin resistance during the early ring stage
Yazar:: Kümpornsin, K, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia.
Yazar:: Sipilanyambe, N, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia
Yazar:: Sipilanyambe, N, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

A PHASE 4 RANDOMISED STUDY TO ASSESS THE TOLERABILITY OF ARTESUNATE-AMODIAQUINE (ASAQ) AND ARTEMETHER-LUMEFANTRINE (AL) FIXED DOSE COMBINATIONS (FDCS) FOR THE TREATMENT OF UNCOMPLICATED PLASMODIUM FALCIPARUM (PF) MALARIA IN LIBERIA
Yazar:: Schramm, B, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

EFFICACY AND SAFETY OF QUININE VS. ARTEMETHER-LUMEFANTRINE IN UNCOMPLICATED MALARIA DURING PREGNANCY, MBARARA, UGANDA
Yazar:: Piola, P, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
Yazar:: Peto, TJ, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia.
Yazar:: Schramm, B, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

The effects of serum lipids on the in vitro activity of lumefantrine and atovaquone against Plasmodium falciparum.
Yazar:: Chotivanich, K, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Other 4-methanolquinolines, amyl alcohols and phentathrenes: Mefloquine, lumefantrine and halofantrine
Yazar:: Nosten, F, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

A case-control auditory evaluation of patients treated with artemether-lumefantrine.
Yazar:: Hutagalung, R, ve diğerleri
Baskı/Yayın Bilgisi: (2006)